Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -25.34% is in line with its 3-year average of -27.87%, around the middle of its 3-year range (-65.35%–22.27%).
38.85% above its 12-month average of -41.44%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-03-31): -65.35%.
OPERATING MARGIN
-25.34%
OPERATING MARGIN AVG TTM
-41.44%
OPERATING MARGIN AVG 3Y
-36.23%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+38.85%
CURRENT VS 3Y AVG
+30.05%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
WORK Medical Technology Group Ltd. Class A
Market Cap
$3.63M
Operating Margin
-25.34%
TTM Avg
-41.44%
3Y Avg
-36.23%
5Y Avg
N/A
Market Cap
$3.65M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$3.65M
Operating Margin
-364.24%
TTM Avg
-350.71%
3Y Avg
-763.84%
5Y Avg
-1461.60%
Market Cap
$3.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.50M
Operating Margin
-3.14%
TTM Avg
-81.95%
3Y Avg
-224.77%
5Y Avg
-179.82%
Market Cap
$3.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
Market Cap
$3.30M
Operating Margin
-2781.69%
TTM Avg
-3688.91%
3Y Avg
-3165.01%
5Y Avg
-3029.85%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| WORK Medical Technology Group Ltd. Class A (WOK) | $3.63M | -25.34% | -41.44% | -36.23% | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| Evogene Ltd. (EVGN)vs › | $3.65M | -364.24% | -350.71% | -763.84% | -1461.60% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -3.14% | -81.95% | -224.77% | -179.82% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 0.00% | 0.00% | -229.94% | -288.65% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -2781.69% | -3688.91% | -3165.01% | -3029.85% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -774.90% | -1185.31% | -1296.90% | -883.94% |
Gross Margin
23.8%
Operating Margin
-25.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -65.35% |
| 2025-09-30 | -17.52% |
| 2025-03-29 | -34.47% |
| 2024-09-29 | -57.08% |
| 2024-03-29 | -9.56% |
| 2023-09-29 | -33.38% |
| 2023-03-29 | 22.27% |
